Digestive Endoscopy Unit, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, 20089 Rozzano, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy.
Medicina (Kaunas). 2022 Feb 22;58(3):331. doi: 10.3390/medicina58030331.
Endoscopic retrograde cholangiopancreatography (ERCP) is considered as the first option in the management of malignant biliary obstruction. In case of ERCP failure, percutaneous transhepatic biliary drainage (PTBD) has been conventionally considered as the preferred rescue strategy. However, the use of endoscopic ultrasound (EUS) for biliary drainage (EUS-BD) has proved similarly high rates of technical success, when compared to PTBD. As a matter of fact, biliary drainage is maybe the most evident paradigm of the increasing interconnection between ERCP and EUS, and obtaining an adequate informed consent (IC) is an emerging issue. The aim of this commentary is to discuss the reciprocal roles of ERCP and EUS for malignant biliary obstruction, in order to provide a guide to help in developing an appropriate informed consent reflecting the new biliopancreatic paradigm.
经内镜逆行胰胆管造影术(ERCP)被认为是治疗恶性胆道梗阻的首选方法。如果 ERCP 失败,经皮经肝胆道引流术(PTBD)通常被认为是首选的抢救策略。然而,与 PTBD 相比,内镜超声(EUS)引导下胆道引流术(EUS-BD)已被证明具有相似的技术成功率。事实上,胆道引流术可能是 ERCP 和 EUS 之间日益紧密联系的最明显范例,获得充分的知情同意书(IC)是一个新出现的问题。本评论的目的是讨论 ERCP 和 EUS 治疗恶性胆道梗阻的相互作用,以提供指导,帮助制定反映新的胆胰模式的适当知情同意书。